HS 2933.33.00
Alfentanil (INN), anileridine (INN), bezitramide (INN)…
Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure › Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), carfentanil (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN), remifentanil (INN) and trimeperidine (INN); salts thereof › Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), carfentanil (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN), remifentanil (INN) and trimeperidine (INN); salts thereof
Total duty from China
0%
- MFN 0%
- GST 5% (recoverable)
Example: value CAD 10,000 → duty $0 → GST 5% $500 (recoverable) → total $10,500
Data updated: 2026-10-12
Compliance checks
Permits and OGD requirements3 OGD requirement(s)3 program(s) may require data or permits at entry
Health Canada
- Permit/licenceHuman DrugsConditions: Intended use HC01, HC02, HC05, HC07 + Product category HC05 | Intended use HC01, HC02, HC05, HC07, HC29, HC31 + Product category HC05, HC06, HC07, HC08, HC09, HC10
- Permit/licenceOffice of Controlled SubstancesConditions: Intended use HC01, HC02, HC10 + Product category HC19, HC20, HC22 | Intended use HC05, HC15, HC28 + Product category HC19, HC20, HC21, HC22
- ConditionalActive Pharmaceutical IngredientsConditions: Intended use HC13 + Product category HC01
Levels summarize each program; the department’s own requirements prevail.